Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Almonty Industries: A Transformational Quarter Sets Stage for Western Tungsten Dominance

Felix Baarz by Felix Baarz
November 13, 2025
in Commodities, Earnings, Penny Stocks, Turnaround
0
Almonty Stock
0
SHARES
31
VIEWS
Share on FacebookShare on Twitter

Almonty Industries has reported third-quarter 2025 financial results that signal a dramatic transformation for the tungsten producer, with key metrics showing substantial improvement and positioning the company for continued growth.

Financial Performance Marks Turning Point

The company’s latest earnings reveal a remarkable financial turnaround. Revenue surged to CAD $8.7 million, representing a 28% increase compared to the CAD $6.8 million recorded during the same period last year. This growth was fueled by stronger tungsten pricing and consistent production output from the Panasqueira mine in Portugal.

Most notably, Almonty swung from a CAD $5.3 million loss in Q3 2024 to a record profit of CAD $33.2 million. This dramatic reversal was primarily driven by a CAD $34.5 million non-cash valuation adjustment on warrants following the conversion from Australian to Canadian dollars.

Strategic Positioning and Expansion Initiatives

Three key strategic developments are strengthening Almonty’s market position:

• Beaverhead County Acquisition: The company secured a strategic tungsten project in Montana for USD $10 million, with production commencement anticipated by late 2026
• Panasqueira Exploration: A comprehensive drilling program involving 14,000 meters over 12 months represents a €2.5 million investment in resource expansion
• Nasdaq Listing: Successful public offering raised USD $90 million, boosting liquidity to CAD $111.6 million

Sangdong Mine Nears Production Milestone

Almonty stands to benefit significantly from the nearing completion of its Sangdong facility in South Korea. The company has transitioned from development to production phase, with commissioning expected to begin imminently.

Should investors sell immediately? Or is it worth buying Almonty?

CEO Lewis Black emphasized the strategic importance: “This quarter represented an inflection point for Almonty. With construction largely complete at Sangdong and production ramp-up commencing, we’re positioned to become the largest tungsten producer in the Western world.”

Analyst Outlook and Market Potential

Market researchers at Oppenheimer maintain their “Buy” recommendation with a $12 price target, suggesting approximately 20% upside from current levels. These experts project revenue will exceed CAD $100 million next year and view CAD $600 million by 2028 as achievable.

The fundamental driver behind this growth trajectory is Almonty’s strategic positioning within critical minerals. Tungsten faces export controls and geopolitical tensions, creating ideal conditions for Western producers.

Geopolitical Factors and Financial Strength

Almonty benefits from increasing Western demand for secure tungsten supply chains. The company’s conflict-free operations in Portugal, South Korea, and the United States position it as a key supplier for defense and high-technology industries affected by China trade disputes.

The current molybdenum drilling program at Sangdong further diversifies Almonty’s critical minerals portfolio, addressing ongoing shortages in this strategic metal market.

With CAD $111.6 million in liquid assets—compared to just CAD $7.8 million at the end of 2024—Almonty possesses sufficient capital to aggressively advance its expansion plans. The negative adjusted EBITDA of CAD $2.2 million in Q3 temporarily reflects development and listing expenses, but this metric is expected to improve rapidly as Sangdong begins production.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from February 7 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Next Post
Barrick Mining Stock

Barrick Gold Shares Maintain Upward Momentum

Ethereum Stock

Ethereum's Multifront Battle for Blockchain Supremacy

Silber Preis Stock

Silver's Meteoric Ascent: Unpacking the Forces Driving Prices Higher

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com